NIH-funded research NIH-funded research

Improving opioid treatment outcomes for people with PTSD

Official title: Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs

Funded at City College of New York · NIH-10812813 · Data updated 2026-11-12

This study is looking to improve treatment for people who inject drugs and also have posttraumatic stress disorder by offering a special therapy right at syringe service programs through telehealth, making it easier for them to manage their PTSD and stick with their medication for opioid use disorder.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCity College of New York
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$915,814
NIH project number1R61DA059032-01A1
Project IDNIH-10812813 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who inject drugs and have a diagnosis of posttraumatic stress disorder.

Less likely to help

Patients who do not have opioid use disorder or PTSD may not receive any benefit from this research.

What this research studies

This research aims to enhance the treatment of opioid use disorder (OUD) in individuals who inject drugs (PWID) and also suffer from posttraumatic stress disorder (PTSD). The project will adapt Cognitive Processing Therapy (CPT), a proven PTSD treatment, to better meet the needs of PWID by delivering it onsite at syringe service programs (SSPs) through telehealth. By addressing PTSD symptoms, the research seeks to improve emotional regulation and retention in lifesaving medication treatments for OUD. The approach includes collaboration with harm reduction organizations to provide flexible and supportive care.

Why it matters

Potential benefit: If successful, this research could significantly improve treatment engagement and outcomes for patients with co-occurring PTSD and opioid use disorder.

How similar studies have gone: Previous research has shown success in adapting PTSD treatments for marginalized populations, indicating potential for this innovative approach.

Where this research is happening

  • City College of New York
    New York, United States
    Active

Researchers

  • Principal investigator: Lopez-Castro, Teresa — City College of New York
  • Study coordinator: Lopez-Castro, Teresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.